Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · IEX Real-Time Price · USD

3.690

0.00 (0.00%)

At close: Jul 19, 2024, 4:00 PM

3.680

-0.010 (-0.27%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Arbutus Biopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2008
Revenue	12.99	18.14	39.02	10.99	6.91	6.01	Upgrade
Revenue Growth (YoY)	-60.80%	-53.51%	255.11%	58.92%	15.02%	1.11%	Upgrade
Gross Profit	12.99	18.14	39.02	10.99	6.91	6.01	Upgrade
Selling, General & Admin	22.24	22.48	17.83	17.14	14.85	17.73	Upgrade
Research & Development	70.83	73.7	84.41	65.5	49.34	57.6	Upgrade
Other Operating Expenses	0	0	0	0	0.06	74.76	Upgrade
Operating Expenses	93.06	96.18	102.24	82.64	64.25	150.09	Upgrade
Operating Income	-80.08	-78.03	-63.22	-71.65	-57.33	-144.07	Upgrade
Interest Expense / Income	0.31	0.46	1.73	2.86	4.01	2.11	Upgrade
Other Expense / Income	-6	-5.64	0.06	1.74	2.4	20.2	Upgrade
Pretax Income	-74.39	-72.85	-65.01	-76.25	-63.75	-166.38	Upgrade
Income Tax	0	0	4.44	0	0	-12.66	Upgrade
Net Income	-74.39	-72.85	-69.46	-76.25	-63.75	-153.72	Upgrade
Preferred Dividends	0	0	0	12.14	12.12	11.15	Upgrade
Net Income Common	-74.39	-72.85	-69.46	-88.39	-75.87	-164.87	Upgrade
Shares Outstanding (Basic)	176	166	151	106	76	57	Upgrade
Shares Outstanding (Diluted)	176	166	151	106	76	57	Upgrade
Shares Change	8.65%	9.95%	42.07%	40.10%	32.83%	3.24%	Upgrade
EPS (Basic)	-0.44	-0.44	-0.46	-0.83	-1.00	-2.89	Upgrade
EPS (Diluted)	-0.44	-0.44	-0.46	-0.83	-1.00	-2.89	Upgrade
Free Cash Flow	-78.9	-86.92	-35.87	-68.34	-51.67	-71.58	Upgrade
Free Cash Flow Per Share	-0.45	-0.52	-0.24	-0.64	-0.68	-1.25	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-616.64%	-430.15%	-162.03%	-652.07%	-829.23%	-2396.84%	Upgrade
Profit Margin	-572.81%	-401.57%	-178.01%	-804.39%	-1097.31%	-2742.84%	Upgrade
Free Cash Flow Margin	-607.55%	-479.16%	-91.92%	-621.96%	-747.32%	-1190.88%	Upgrade
EBITDA	-72.66	-70.99	-61.86	-71.64	-57.76	-162.24	Upgrade
EBITDA Margin	-559.49%	-391.30%	-158.54%	-651.96%	-835.35%	-2699.10%	Upgrade
Depreciation & Amortization	1.43	1.4	1.43	1.75	1.98	2.03	Upgrade
EBIT	-74.08	-72.39	-63.29	-73.39	-59.73	-164.27	Upgrade
EBIT Margin	-570.46%	-399.04%	-162.19%	-667.91%	-863.96%	-2732.84%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).